These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28394351)

  • 21. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
    O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
    J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy.
    Querenghi F; Yu Q; Billaud G; Maertens G; Trépo C; Zoulim F
    J Viral Hepat; 2001 Mar; 8(2):120-31. PubMed ID: 11264732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic diversity of near genome-wide hepatitis C virus sequences during chronic infection: evidence for protein structural conservation over time.
    Li H; Hughes AL; Bano N; McArdle S; Livingston S; Deubner H; McMahon BJ; Townshend-Bulson L; McMahan R; Rosen HR; Gretch DR
    PLoS One; 2011 May; 6(5):e19562. PubMed ID: 21573177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy.
    Halfon P; Halimi G; Bourlière M; Ouzan D; Durant J; Khiri H; Mercier L; Gerolami V; Cartouzou G
    Liver; 2000 Oct; 20(5):381-6. PubMed ID: 11092256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of drug resistance and immune-driven variations in hepatitis C virus (HCV) NS3/4A, NS5A and NS5B regions reveals a new approach toward personalized medicine.
    Ikram A; Obaid A; Awan FM; Hanif R; Naz A; Paracha RZ; Ali A; Janjua HA
    Antiviral Res; 2017 Jan; 137():112-124. PubMed ID: 27984060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.
    Hayashi K; Katano Y; Kuzuya T; Tachi Y; Honda T; Ishigami M; Itoh A; Hirooka Y; Ishikawa T; Nakano I; Urano F; Yoshioka K; Toyoda H; Kumada T; Goto H
    J Med Virol; 2012 Mar; 84(3):438-44. PubMed ID: 22246829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotypes 2a and 2b and high viral load.
    Kim SR; El-Shamy A; Imoto S; Kim KI; Sugimoto K; Kim SK; Tanaka Y; Hatae T; Hasegawa Y; Fujinami A; Ohta M; Hotta H; Kudo M
    Dig Dis; 2013; 31(5-6):426-33. PubMed ID: 24281016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of IL28B for chronic hepatitis C treatment toward personalized medicine.
    Matsuura K; Watanabe T; Tanaka Y
    J Gastroenterol Hepatol; 2014 Feb; 29(2):241-9. PubMed ID: 24325405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus NS3/4A protease blocks IL-28 production.
    Ding Q; Huang B; Lu J; Liu YJ; Zhong J
    Eur J Immunol; 2012 Sep; 42(9):2374-82. PubMed ID: 22685015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population.
    Shan Z; Huang J; Liao Q; Huang K; Wang M; Xu R; Tang X; Zhang W; Nelson K; Fu Y; Li C; Rong X
    Transfusion; 2018 Apr; 58(4):1028-1035. PubMed ID: 29446443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.
    Rauch A; James I; Pfafferott K; Nolan D; Klenerman P; Cheng W; Mollison L; McCaughan G; Shackel N; Jeffrey GP; Baker R; Freitas E; Humphreys I; Furrer H; Günthard HF; Hirschel B; Mallal S; John M; Lucas M; Barnes E; Gaudieri S
    Hepatology; 2009 Oct; 50(4):1017-29. PubMed ID: 19670417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host - hepatitis C viral interactions: The role of genetics.
    Heim MH; Bochud PY; George J
    J Hepatol; 2016 Oct; 65(1 Suppl):S22-S32. PubMed ID: 27641986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate and adaptive genetic pathways in HCV infection.
    Buchanan R; Hydes T; Khakoo SI
    Tissue Antigens; 2015 Apr; 85(4):231-40. PubMed ID: 25708172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1.
    Jacobson I; Zeuzem S; Flisiak R; Knysz B; Lueth S; Zarebska-Michaluk D; Janczewska E; Ferenci P; Diago M; Zignego AL; Safadi R; Baruch Y; Abdurakhmanov D; Shafran S; Thabut D; Bruck R; Gadano A; Thompson AJ; Kopit J; McPhee F; Michener T; Hughes EA; Yin PD; Noviello S
    World J Gastroenterol; 2016 Mar; 22(12):3418-31. PubMed ID: 27022224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The NS5a gene of hepatitis C virus in patients treated with interferon-alpha.
    McKechnie VM; Mills PR; McCruden EA
    J Med Virol; 2000 Apr; 60(4):367-78. PubMed ID: 10686018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HCV genome variability in acute and chronic viral hepatitis C].
    Iushchuk ND; Klimova EA; Znoĭko OO; Gadzhikulieva MM; Il'ina EN; Iashina TL; Malyshev NA; Tsyganova EV
    Ter Arkh; 2009; 81(4):47-55. PubMed ID: 19514422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population.
    Chuang WC; Sarkodie F; Brown CJ; Owusu-Ofori S; Brown J; Li C; Navarrete C; Klenerman P; Allain JP
    J Med Virol; 2007 Jun; 79(6):724-33. PubMed ID: 17546694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3.
    Rembeck K; Alsiö A; Christensen PB; Färkkilä M; Langeland N; Buhl MR; Pedersen C; Mørch K; Westin J; Lindh M; Hellstrand K; Norkrans G; Lagging M
    PLoS One; 2012; 7(1):e29370. PubMed ID: 22253715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
    J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.